| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 105,335 | 87,864 | 100,336 | | Cost of Revenue | 5,435 | 9,020 | 9,780 | | | Gross Profit | 99,900 | 78,844 | 90,557 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,305 | 1,606 | 1,678 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 98,595 | 77,238 | 88,879 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (310,164) | (100,742) | (59,122) | | Earnings Before Interest And Taxes | 61,854 | 77,238 | 86,346 | | Interest Expense | 410 | 7 |
-
| | Income Before Tax | 61,443 | 77,231 | 86,346 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (211,979) | (23,511) | 29,757 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (211,979) | (23,511) | 29,757 | | Preferred Stock And Other Adjustments | (8,435) | (22,370) | (24,412) | | | Net Income Applicable To Common Shares | ($220,413) | ($45,881) | $5,345 |
|
0.29% Nasdaq 0.00%
Income Statement
